Risks and Indications
Patients undergoing radiofrequency ablation are subject to risks associated with surgery including complications from anesthesia/sedation, as well as bleeding, bruising, pain and infection. Additional complications could include: blood clots, collapsed lungs, and damage to normal tissue, nerves, the spinal cord or other structures resulting in injuries including paralysis.
The STAR Tumor Ablation System does not treat cancer. It is indicated for palliative treatment (i.e., pain relief) in spinal procedures by ablation of metastatic malignant lesions in a vertebral body.
The STAR Tumor Ablation System is contraindicated for:
• lesions in the cervical levels of the spine.
• patients with pacemakers or other electronic implants.
Every patient is different. Not every patient is a candidate for t-RFA. You should discuss risks, benefits, and expectations of a procedure, including recovery time, with your physician.
Pain Relief from Metastatic Spinal Tumors with the STARTM Tumor Ablation System
Finding fast and lasting relief from painful metastatic spinal lesions is now possible with minimally invasive targeted radiofrequency ablation (t-RFA).
Using the STAR Tumor Ablation System, t-RFA delivers meaningful pain relief and focused tumor destruction in a single treatment, often performed in an outpatient setting.
With the STAR System, physicians create site-specific treatment zones within the vertebral body.
Compatible with systemic therapies, t-RFA expands the range of treatment options for many patients with painful spinal tumors.
Ask your physician about the STAR Tumor Ablation System for the treatment of metastatic spinal tumors.